Sep 13, 2013

1st SCID NBS Assay Commercially Available

Perkin Elmer recently announced the launch of the first commercially available screening test for Severe Combined Immunodeficiencies (SCID). SCID is one of the most severe forms of primary immunodeficiencies affecting 1 in 50,000 to 1 in 100,000 babies every year. Higher incidence has also been shown in certain countries and regions. More information can be found on Perkin Elmer's Official Press Release.



World PI Week
Donations
banner2
IPOPI would be grateful for any support to the important work for primary immunodeficiencies.

Read all

Contact
Executive Director: Johan Prevot
Email: johan@ipopi.org
Tel/Fax: +351 21 407 5720
UK office
Firside Main Road Downderry
Cornwall PL11 3LE
United Kingdom

Tel: +44 1503 250 668
Fax: +44 1503 250 961
E-mail: info@ipopi.org
IPOPI is a charity registered in the UK.
Registration No. 1058005